‌

US Patent 10842882 Amatoxin-antibody conjugates

Patent 10842882 was granted and assigned to Heidelberg Pharma on November, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Heidelberg Pharma

Current Assignee

Heidelberg Pharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10842882

Date of Patent

November 24, 2020

Patent Application Number

15556830

Date Filed

March 7, 2016

Patent Citations Received

‌

US Patent 11590238 Amanitin conjugates

Patent Primary Examiner

‌

Karen A. Canella

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10842882 Amatoxin-antibody conjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API